Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Study designs of randomized controlled trials not based on Chinese medicine theory are improper. | Chinese Medicine BioMed Central Open Access Study designs of randomized controlled trials not based on Chinese medicine theory are improper Jian Yan 1 Veronica F Engle2 Yuxin He3 Yan Jiao4 and Weikuan Gu4 Address 1Molecular Resource Center University of Tennessee Health Science Center Memphis TN 38163 USA 2Department of Primary Care Nursing and Department of Preventive Medicine University of Tennessee Health Science Center Memphis TN 38163 USA 3Acupuncture Chinese Medical Center Austin TX 78757 USA and 4Department of Orthopedics Surgery University of Tennessee Health Science Center Memphis TN 38163 USA Email Jian Yan - jyan1@ Veronica F Engle - vengle@ Yuxin He - Dryuxinhe@ Yan Jiao - yjiao2@ Weikuan Gu - wgu@ Corresponding author Published 25 February 2009 Received 7 July 2006 Accepted 25 February 2009 ChineseMedicine 2009 4 3 doi 1749-8546-4-3 This article is available from http content 4 1 3 2009 Yan et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ Current biomedical research methods to evaluate the efficacy of Chinese medicine interventions are often conceptually incompatible with the theory and clinical practice of Chinese medicine. In this commentary we 1 highlight the theory and principles underlying Chinese medicine clinical practice 2 use ginseng as an example to describe clinical indications in Chinese medicine 3 propose a framework guided by Chinese medicine theory for the evaluation of study designs in Chinese medicine research and 4 evaluate 19 randomized double-blind placebo-controlled trials of ginseng. Our analysis indicates that all 19 trials with
